Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GENERTEC UNIVERSAL MEDICAL GROUP COMPANY

LIMITED

通用環球醫療集團有限公司

(Incorporated in Hong Kong with limited liability)

(Stock Code2666)

COMPLETION OF THE ISSUANCE OF DOMESTIC MEDIUM-TERM

NOTES IN THE PRC

BY CHINA UNIVERSAL LEASING CO., LTD., A WHOLLY-OWNED

SUBSIDIARY OF THE COMPANY

This announcement is made by Genertec Universal Medical Group Company Limited (the "Company") pursuant to Rule 13.09(2)(a) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions (as defined under the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571, Laws of Hong Kong).

Reference is made to the announcement of the Company dated 31 March 2021 (the "Announcement") in relation to the proposed issuance of the first tranche of domestic medium-term notes (the "Notes") of an aggregate principal amount of up to RMB1 billion by China Universal Leasing Co., Ltd. (中國環球租賃有限公司), a wholly-owned subsidiary of the Company. Unless the context requires otherwise, capitalized terms used herein shall have the same meanings as those defined in the Announcement.

1

The Company is pleased to announce that the issuance of the Notes in the PRC was completed on 7 April 2021 and the actual issuance amount is RMB500 million. The maturity of the Notes will be two years from 8 April 2021, with a fixed interest rate of 4.3% and issue price of RMB100 per note, which is equal to 100% of the principal value of the Notes.

By order of the Board

Genertec Universal Medical Group Company

Limited

通用環球醫療集團有限公司

Peng Jiahong

Executive Director

Beijing, PRC, 8 April 2021

As at the date of this announcement, the executive directors of the Company are Ms. Peng Jiahong (Vice-chairwoman) and Mr. Yu Gang; the non-executive directors of the Company are Mr. Zhang Yichen (Chairman), Ms. Liu Kun and Mr. Liu Zhiyong; and the independent non-executive directors of the Company are Mr. Li Yinquan, Mr. Chow Siu Lui, Mr. Han Demin and Mr. Liao Xinbo.

2

Attachments

  • Original document
  • Permalink

Disclaimer

Genertec Universal Medical Group Co. Ltd. published this content on 08 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 April 2021 09:17:08 UTC.